<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To accurately assess the management and complications of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in urban Indigenous Australians and compare the risk of complications with a general Australian population (AusDiab Study) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The Darwin Region Urban Indigenous <z:mp ids='MP_0002055'>Diabetes</z:mp> (DRUID) Study included 1004 volunteers aged &gt;/=15 years; <z:mp ids='MP_0002055'>diabetes</z:mp> status was classifiable for 866 </plain></SENT>
<SENT sid="2" pm="."><plain>The assessment of <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> and metabolic control was performed in participants with known <z:mp ids='MP_0002055'>diabetes</z:mp> (KDM) and <z:mp ids='MP_0002055'>diabetes</z:mp> newly diagnosed by the study (NDM) using an interviewer-administered questionnaire and clinical examination </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Among 172 DRUID participants eligible for complications assessment, 135 were assessed, including 99 KDM (mean age 53 years) and 36 NDM (mean age 47 years) </plain></SENT>
<SENT sid="4" pm="."><plain>Percentages of KDM participants meeting therapeutic targets were: HbA1c&lt;7%, 29%; blood pressure&lt;130/80mmHg, 45%; total cholesterol&lt;5.5mmol/L, 65% </plain></SENT>
<SENT sid="5" pm="."><plain>Among KDM, 39% had <z:mp ids='MP_0002871'>albuminuria</z:mp>, 21% <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, 12% <z:hpo ids='HP_0004950'>peripheral vascular disease</z:hpo> (PVD), 9% <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Factors independently associated with <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> were: <z:mp ids='MP_0002871'>albuminuria</z:mp>-HbA1c, systolic blood pressure; <z:hpo ids='HP_0000488'>retinopathy</z:hpo>-<z:mp ids='MP_0002055'>diabetes</z:mp> duration; PVD-age </plain></SENT>
<SENT sid="7" pm="."><plain>Compared to AusDiab participants after adjusting for other risk factors, DRUID participants had 2-3-fold increased risk of <z:mp ids='MP_0002871'>albuminuria</z:mp> and PVD and a non-significant increased risk of <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e>, but no increased risk of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Urban Indigenous Australians with <z:mp ids='MP_0002055'>diabetes</z:mp> are relatively young and have poor glycaemic control </plain></SENT>
<SENT sid="9" pm="."><plain>Compared to the general Australian population with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, they have greater adjusted risk of <z:mp ids='MP_0002871'>albuminuria</z:mp> and PVD but not <z:hpo ids='HP_0000488'>retinopathy</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Urgent action is required to prevent <z:mp ids='MP_0002055'>diabetes</z:mp> at a population level and improve <z:mp ids='MP_0002055'>diabetes</z:mp> management in this high-risk population </plain></SENT>
</text></document>